Filing Details

Accession Number:
0001213900-19-027008
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-12-26 16:31:33
Reporting Period:
2019-12-20
Accepted Time:
2019-12-26 16:31:33
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1218683 Wize Pharma Inc. WIZP Pharmaceutical Preparations (2834) 880445167
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1723667 Brian Jonathan Rubini 813 D Street
Anchorage AK 99501
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-12-20 2,037,037 $0.27 2,455,739 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Warrants Acquisiton 2019-12-20 4,074,047 $0.00 4,074,047 $0.27
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
4,074,047 2024-12-19 No 4 P Direct
Footnotes
  1. Exercisable five days following the public announcement of positive clinical data results for LO2A